{"id":273,"date":"2018-12-01T17:48:45","date_gmt":"2018-12-01T08:48:45","guid":{"rendered":"http:\/\/www.medphas.kumamoto-u.ac.jp\/cmha\/?p=273"},"modified":"2018-12-01T17:48:45","modified_gmt":"2018-12-01T08:48:45","slug":"2019011001-2","status":"publish","type":"post","link":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/2019011001-2\/","title":{"rendered":"\u30c0\u30ca-\u30d5\u30a1\u30fc\u30d0\u30fc\u764c\u7814\u7a76\u6240\u3068\u99ac\u5834\u79c0\u592b\u6559\u6388\u306e\u5171\u540c\u7814\u7a76\u8ad6\u6587\u304cClinical Cancer Research\u8a8c\u306b\u63b2\u8f09\u3055\u308c\u307e\u3057\u305f\u3002"},"content":{"rendered":"<p><span lang=\"ja\"><span style=\"font-family: \u6e38\u30b4\u30b7\u30c3\u30af; font-size: small;\"><span style=\"font-family: Arial,sans-serif; font-size: small;\"><span lang=\"en-US\">Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer. <\/span><\/span><b><i><\/i><\/b><\/span><\/span><\/p>\n<p><span lang=\"ja\"><span style=\"font-family: \u6e38\u30b4\u30b7\u30c3\u30af; font-size: small;\"><span style=\"font-family: Arial,sans-serif; font-size: small;\"><span lang=\"en-US\">Bahcall M, Awad MM, Sholl LM, Wilson FH, Xu M, Wang S, Palakurthi S, Choi J, Ivanova EV, Leonardi GC, Ulrich BC, Paweletz CP, Kirschmeier PT, Watanabe M, Baba H, Nishino M, Nagy RJ, Lanman RB, Capelletti M, Chambers ES, Redig AJ, VanderLaan PA, Costa DB, Imamura Y, Janne PA<\/span><\/span><\/span><\/span><\/p>\n<p><span lang=\"ja\"><span style=\"font-family: \u6e38\u30b4\u30b7\u30c3\u30af; font-size: small;\"><span style=\"font-family: Arial,sans-serif; font-size: small;\"><span lang=\"en-US\"><b><i>Clin Cancer Res<\/i><\/b><\/span><\/span><span style=\"font-family: Arial,sans-serif; font-size: small;\"><span lang=\"en-US\"> 24(23):5963-5976, 2018.<\/span><\/span><\/span><\/span><\/p>\n<p>DOI: 10.1158\/1078-0432.CCR-18-0876.<\/p>\n<p>&nbsp;<\/p>\n<p>\u8ad6\u6587\u306e\u8a73\u7d30\u306f<a href=\"http:\/\/clincancerres.aacrjournals.org\/content\/24\/23\/5963.long\">\u30b3\u30c1\u30e9<\/a>\u304b\u3089<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Can [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-273","post","type-post","status-publish","format-standard","hentry","category-research"],"_links":{"self":[{"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/posts\/273","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/comments?post=273"}],"version-history":[{"count":0,"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/posts\/273\/revisions"}],"wp:attachment":[{"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/media?parent=273"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/categories?post=273"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/srv02.medic.kumamoto-u.ac.jp\/cmha\/wp-json\/wp\/v2\/tags?post=273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}